Interestingly, in vivo and in vitro studies suggest that an excess of Zn can represent a risk factor for the development of AD, as it promotes APP expression, β-secretase cleavage, and Aβ deposition and aggravates tauopathy, resulting in learning and memory impairment [594,595]. This evidence concerns the gene APP and memory impairment.